Guidelines on the use and monitoring of heparin
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abdu R., 1987, Mesenteric vein thrombosis – 1911 to 1984, Surgery, 101, 383
Alhenc‐Gelas M., 1994, Adjusted versus fixed doses of low molecular weight heparin Fragmin in the treatment of deep venous thrombosis, Thrombosis and Haemostasis, 71, 698, 10.1055/s-0038-1642507
Anand S., 1996, The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin, Archives of Internal Medicine, 156, 12, 10.1001/archinte.1996.00440140107010
Barrowcliffe T.W., 1988, An international standard for low molecular weight heparin, Thrombosis and Haemostasis, 60, 1, 10.1055/s-0038-1647623
Béguin S., 1990, Mode of action of enoxaparin in plasma, Acta Chirurgica Scandanavia Suppl, 556, 51
Béguin S., 1988, The mode of action of heparin in plasma, Thrombosis and Haemostasis, 6, 457
Béguin S., 1989, The action of a synthetic pentasaccharide on thrombin generation in whole plasma, Thrombosis and Haemostasis, 61, 397, 10.1055/s-0038-1646603
Béguin S., 1989, The mode of action of low molecular weight heparin preparation (PK1069) and two of its major components on thrombin generation in plasma, Thrombosis and Haemostasis, 61, 30, 10.1055/s-0038-1646522
Béguin S., 1992, The mode of action of CY216 and CY222 in plasma, Thrombosis and Haemostasis, 67, 33, 10.1055/s-0038-1648375
Bombeli T., 2001, Evaluation of an optimal dose of low‐molecular‐weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers, Haemostasis, 31, 90
Boneu B., 1990, Antithrombotic Therapy, 531
Cohen A.T., 2001, Extended thromboprophylaxis with LMWH reduces symptomatic venous thromboembolism following lower limb arthroplasty – a meta‐analysis, Thrombosis and Haemostasis, 85, 940, 10.1055/s-0037-1615775
Cohen A.T., 2003, Fondaparinux versus placebo for the prevention of venous thromboembolism in acutely ill medical patients (Artemis), Journal of Thrombosis and Haemostasis, 1, P2046
Diness V., 1986, Neutralization of a low molecular weight heparin (LHN‐1) and conventional heparin by protamine sulfate in rats, Thrombosis and Haemostasis, 56, 318, 10.1055/s-0038-1661675
Douketis J.D., 1996, The effects of long‐term heparin therapy during pregnancy on bone density. A prospective matched cohort study, Thrombosis and Haemostasis, 75, 254, 10.1055/s-0038-1650255
Eriksson B.I., 1995, A comparative study of three low‐molecular weight heparins and unfractionated heparin in healthy volunteers, Thrombosis and Haemostasis, 73, 398, 10.1055/s-0038-1653787
Greaves M., 2002, Limitations of the laboratory monitoring of heparin therapy, Thrombosis and Haemostasis, 87, 163, 10.1055/s-0037-1612960
Handoll H.H., 2002, Cochrane Database Systematic Review, 4
Hemker H.C., 1993, The activity of heparin in the presence and absence of calcium ions; why the anti‐Xa activity of LMW heparins is about two times overestimated, Thrombosis and Haemostasis, 70, 717, 10.1055/s-0038-1649656
Holmer E., 1983, Neutralisation of unfractionated heparin and a low molecular weight (LMW) heparin fragment by protamine, Thrombosis and Haemostasis, 50, 103
Hunt B.J., 1997, Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies, Thrombosis and Haemostasis, 77, 39, 10.1055/s-0038-1655903
International Stroke Trial (IST) Collaborative Group, 1998, A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial, Lancet, 349, 1569
Kitchen S., 1999, Anti‐Xa monitoring during treatment of LMWH or danaparoid: inter‐assay variability, Thrombosis and Haemostasis, 82, 1289, 10.1055/s-0037-1614377
Koch A., 1997, Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta‐analyses, British Journal of Surgery, 84, 50
Leizorovicz A., 1993, Factor Xa inhibition: correlation between the plasma levels of anti‐Xa activity and occurrence of thrombosis and haemorrhage, Haemostasis, 23, 89
Lensing A.W., 1995, Treatment of deep venous thrombosis with low‐molecular‐weight heparin, Archives of Internal Medicine, 155, 601, 10.1001/archinte.1995.00430060059007
Magee K.D., 2003, Cochrane Database Systematic Review, 1
Monreal M., 1994, Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin, Thrombosis and Haemostasis, 71, 7, 10.1055/s-0038-1642376
Ng H.J., 2003, Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin, Annals of Haematology, 82, 257, 10.1007/s00277-003-0633-1
Niewenhuis H.K., 1991, Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin, Blood, 78, 2337, 10.1182/blood.V78.9.2337.2337
Oler A., 1996, Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta‐analysis, Journal of the American Medical Association, 276, 811, 10.1001/jama.1996.03540100055028
Peyrou V., 1997, The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma – the need for using absolute anti‐factor Xa and antithrombin activities, Thrombosis and Haemostasis, 77, 312, 10.1055/s-0038-1655960
Upchurch G.R., 1995, Efficacy of subcutaneous heparin in prevention of venous thromboembolic events in trauma patients, American Journal of Surgery, 61, 749
Van den Besselaar A.M.H.P., 1987, Monitoring heparin therapy by the APTT – the effect of pre‐analytical conditions, Thrombosis and Haemostasis, 57, 226, 10.1055/s-0038-1651099
Veen J.J., 2005, Clinical use of protamine for the emergency reversal of anticoagulation with LMWH, British Journal of Haematology, 129, 17
Wichers I.M., 2005, Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review, Haematologica, 90, 672